Biotech raises $315 million in IPO, surpassing $250M target
September 13, 2024 at 09:47 AM EDT
Bicara Therapeutics, led by CEO Claire Mazumdar, develops cancer drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|